ORTEXORTEX News
Tracking ODD? Get live short interest, options flow, and signals on ORTEX.Sign up free →
OD
Earnings PreviewODD

ODD Calls Surge as Bears Brace for Today's Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 9 Sept 2026, 03:51

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Oddity Tech heads into today's Q3 earnings with one of the most extreme options setups in the market right now — and the signals point in opposite directions.

The clearest anomaly is in options. Call demand has overwhelmed puts to a degree that rarely happens. The put/call ratio has collapsed to 0.42, nearly three standard deviations below its 20-day average of 0.78 — the most bullish positioning in the past year. This is a sharp and sudden reversal: for most of August, the PCR sat consistently above 0.80, suggesting the two-day swing into this week's print represents a deliberate repositioning rather than drift. Someone is making a directional bet on an upside surprise.

Short interest tells a more cautious story for the bulls. At 14.1% of free float, short positioning remains elevated — up 7% versus a month ago — though it eased slightly on the week. Borrow cost has been falling and now sits at 1.82%, down from 3.5% in early August. Availability is in the tight-to-normal range at 59%, having loosened meaningfully from lows near 24% in late July. The ORTEX short score has crept up to 75.7, ranking in the bottom 5th percentile of the universe, which flags this as a name where short pressure is real and persistent even as borrow conditions ease. The stock itself is down 8% on the week and 8% on the month, trading at $13.03 — a fragile price that amplifies the stakes for today's number.

The analytical community is not constructive. After a June print that sent the stock down nearly 27% in a single session, the Street cut targets hard. Goldman downgraded to Sell with a $8 target. Morgan Stanley and Barclays both sit at Underweight or Equal-Weight with targets in the $8–10 range. In the only meaningful post-crash move, Truist raised its target from $12 to $16 last week while keeping a Hold — a tepid endorsement. The mean analyst target of $11.64 is actually below the current price, so the Street's base case implies further downside from here. The bear case centres on a 30%+ expected revenue decline driven by problems with the company's largest advertising partner and an absence of FY26 guidance; the bull case rests on direct-to-consumer growth running at 24% year-on-year and gross margins above 70%.

The institutional register adds an interesting wrinkle. Baillie Gifford has grown its stake to 22.4% of the company, up from 17.3%, making it the largest external institutional holder. BlackRock filed a fresh 13G in late July disclosing 9.9%. These are not momentum traders — their continued buying through the post-crash period suggests conviction at lower prices, even as all 13D/G disclosures carry the standard caveat that stakes are as-last-disclosed and holders can exit without further filing below the 5% threshold. Against that backdrop, the extreme call positioning and the institutional buying stand against a still-heavy short base and a Street consensus sitting in sell territory. Today's print will test whether the recovery narrative around ad-channel diversification and margin improvement holds — or whether the June collapse was the opening act.

Stocks in this article

See the live data behind this article on ORTEX.

Open ODD on ORTEX →

How this article was generated

Generated
9 Sept 2026, 04:02
Data as of
9 Sept 2026, 03:51
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.